0. rcn3028
Hot Flashes
Yung Shin Pharm. Ind. Co., Ltd.Phase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Hot Flashes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Mayo Clinic | Phase 3 | BB |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Northwestern University | Phase 4 | BB |
Seroquel® McMaster University | Phase 4 | BB |
TAMOXIFEN Astellas Pharma Global Development, Inc. | Phase 3 | BB |
DESVENLAFAXINE Seoul National University Hospital | Phase 4 | BB |
View all 31 →
Same molecule, other indications
0. rcn3028 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →